Securing Medical Supplies and Supporting Medical Institutions During the COVID-19 Pandemic
First written in FY2021-Q1. 4 of 7 entries say "Advanced", first in FY2021-Q2. Latest entry: FY2022.
1 other company's latest entry also says "Restated".
- FY2022RestatedAnnual report
「Meanwhile, we newly received contracts for various infectious disease countermeasure services, including the development and operation of the Osaka COVID-19 Large-Scale Medical and Care Center.」
In addition to sales of medical supplies and equipment during the pandemic, contracted medical-institution support services, including the development and operation of the Osaka COVID-19 Large-Scale Medical and Recuperation Center, have been identified. - FY2022-Q2AdvancedAnnual report
「Meanwhile, the company newly undertook various services related to infectious disease control, including the development and operation of the Osaka COVID-19 Large-Scale Medical and Recuperation Center.」
Efforts related to infection control expanded beyond sales of medical supplies and equipment into new contracted services, including the development and operation of the Osaka COVID-19 Large-Scale Medical and Recuperation Center. - FY2022-Q1AdvancedAnnual report
「In the Total Pack Produce business, sales of infection-control equipment, such as simple negative-pressure units, by the manufacturer-related business remained strong, although」
Increased sales of infection-control equipment, such as simple negative-pressure units, are identified as a specific contribution to the performance of the Total Pack Produce business. - FY2021AdvancedAnnual report
「Orders related to infection-control measures increased in the Total Pack Produce business. Sales of infection-control products, including the Airness low-concentration ozone generator and the original SHIP Mask brand, which emphasises domestic production, remained firm and progressed broadly in line with plan.」
Efforts to support medical institutions and secure supplies expanded into stronger business performance, including increased orders related to infection control measures and steady sales of “Airness” and “SHIP Mask.” - FY2021-Q3RestatedAnnual report
「Furthermore, due to the need for infection-control measures, inquiries increased for the company’s private-label domestic surgical mask, SHIP Mask, and the Airness series of low-concentration ozone generators, expanding new sales channels that had not previously existed.」
Inquiries for infection-control products and the expansion of new sales channels continue. The development of the SHIP Mask and Airness series identified in the previous quarter is continuing. - FY2021-Q2AdvancedAnnual report
「In addition, due to the need for infection-control measures, inquiries increased for the company’s private-label domestic surgical mask, SHIP Mask, and the Airness series of low-concentration ozone generators, among other products, expanding new sales channels.」
In addition to securing medical supplies and supporting medical institutions, sales of the SHIP Mask and Airness series as infection-control products progressed, along with the expansion of new sales channels. - FY2021-Q1First statedAnnual report
「The Group also worked to secure necessary supplies, including medical equipment and medical materials, and responded by providing the maximum possible support.」
Amid the spread of COVID-19, the company has for the first time described securing necessary supplies, including medical equipment and medical materials, and supporting medical institutions as a standalone initiative.